Skip to content

Clinical trials

Phase 3 Narcolepsy trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 3 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20044
20152
20161
20201
20212
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon3
Jazz Pharmaceuticals3
Avadel2
Axsome Therapeutics, Inc.2
Alkermes, Inc.1
Harmony Biosciences Management, Inc.1
Orphan Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy13
Cataplexy8
Disorders of Excessive Somnolence8
Sleep Apnea, Obstructive3
Fatigue2
Sleep Wake Disorders2
Parasomnias1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.